Cholecystokinin and Adrenal-Cortex Secretion

Vitamins and Hormones

Volumn 71, Issue , 2005, Pages 433-453

  Nussdorfer, Gastone G ^a   Spinazzi, Raffaella ^a   Mazzocchi, Giuseppina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; GLUCOCORTICOID;

ADRENAL CORTEX; ADRENAL GLAND; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HOMEOSTASIS; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SECRETION; SIGNAL TRANSDUCTION;

ADRENAL CORTEX; ADRENAL GLANDS; ALDOSTERONE; AMINO ACID SEQUENCE; ANIMALS; CHOLECYSTOKININ; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; MOLECULAR SEQUENCE DATA; PITUITARY GLAND; RECEPTORS, CHOLECYSTOKININ; SIGNAL TRANSDUCTION;

EID: 27744523313     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(05)71015-3     Document Type: Review

References (122)

1. Aarnisalo A.M., Vainio P.J., Mannisto P.T., Vasar E., and Tuominen R.K. Evidence for cholecystokinin A receptors in bovine adrenal chromaffin cells. Neuroreport 7 (1996) 2167-2170
2. Abelson J.L., and Liberzon I. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology 21 (1999) 485-494
3. Abelson J.L., and Young E.A. Hypothalamic-pituitary-adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition. Psychoneuroendocrinology 28 (2003) 169-180
4. Abelson J.L., Nesse R.M., and Vinik A.I. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol. Psychiat. 36 (1994) 84-96
5. Ahima R.S., and Flier J.S. Leptin. Annu. Rev. Physiol. 62 (2000) 413-437
6. Albertin G., Malendowicz L.K., Macchi C., Markowska A., and Nussdorfer G.G. Cerebellin stimulates the secretory activity of rat adrenal gland: In vitro and in vivo studies. Neuropeptides 34 (2000) 7-11
7. Andreis P.G., Neri G., Prayer-Galetti T., Rossi G.P., Gottardo G., Malendowicz L.K., and Nussdorfer G.G. Effects of adrenomedullin on the human adrenal glands: An in vitro study. J. Clin. Endocrinol. Metab. 82 (1997) 1167-1170
8. Anhut H., Meyer D.K., and Knepel W. Cholecystokinin-like immunoreactivity of rat medial basal hypothalamus: Investigations on a possible hypophysiotropic function. Neuroendocrinology 36 (1983) 119-124
9. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 7 (1986) 351-378
10. Bardram L., Hilsted L., and Rehfeld J.F. Cholecystokinin, gastrin and their precursors in pheochromocytomas. Acta Endocrinol. (Copenh.) 120 (1989) 479-484
11. Beinfeld M.C. CCK mRNA expression, pro-CCK processing, and regulated secretion of immunoreactive CCK peptides by rat insulinoma (RIN F5) and mouse pituitary tumor (AtT-20) cell in culture. Neuropeptides 22 (1992) 213-217
12. Bernet F., Bernard J., Laborie C., Montel V., Maubert E., and Dupouy J.P. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerulosa zone could be mediated by catecholamines via β1 adrenergic receptors. Neurosci. Lett. 166 (1994) 109-112
13. 18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa. Regul. Pept. 52 (1994) 187-194
14. Bhatnagar S., Viau V., Chu A., Soriano L., Meijer O.C., and Dallman M.F. A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J. Neurosci. 20 (2000) 5564-5573
15. Biró E., Sarnyai Z., Penke B., Szabó G., and Telegdy G. Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology 57 (1993) 340-345
16. Bondy C.A., Jensen R.T., Brady L.S., and Gainer H. Cholecystokinin evokes secretion of oxytocin and vasopressin from the rat neural lobe independent of external calcium. Proc. Natl. Acad. Sci. USA 86 (1989) 5198-5201
17. Buckingham J.C., Smith T., and Loxley D.H. The control of ACTH secretion. In: James V.H.T. (Ed). "The Adrenal Gland" (1992), Raven, New York 131-158
18. Calogero A.E., Nicolosi A.M.G., Moncada M.L., Coniglione F., Vicari E., Polosa P., and D' Agata R. Effects of cholecystokinin octapeptide on the hypothalamic-pituitary-adrenal axis function and on vasopressin, prolactin and growth hormone release in humans. Neuroendocrinology 58 (1993) 71-76
19. 28,31)-CCK25-33S. Eur. J. Neurosci. 4 (1992) 563-573
20. Cecatteli S., Eriksson M., and Hokfelt T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 49 (1989) 309-323
21. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-755
22. Day H.E.W., and Akil H. Evidence that cholecystokinin receptors are not involved in the hypothalamic-pituitary-adrenal response to intraperitoneal administration of interleukin-1β. J. Neuroendocrinol. 11 (1999) 561-568
23. Degli Uberti E.C., Trasforini G., Margutti A.R., Rotola C.A., and Pansini R. Effect of pentagastrin on adrenocorticotropin hormone and thyroid-stimulating hormone release in normal subjects. Horm. Res. 17 (1983) 74-77
24. Delarue C., Contesse V., Lenglet S., Sicard F., Perraudin V., Lefebvre H., Kodjo M., Leboulenger F., Yon L., Gallo-Payet N., and Vaudry H. Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex. Rev. Endocr. Metabol. Disord. 2 (2001) 253-267
25. Delarue C., Conlon J.M., Remy-Jouet I., Fournier A., and Vaudry H. Endothelins as local activators of adrenocortical cells. J. Mol. Endocrinol. 32 (2004) 1-7
26. De Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers Preliminary findings. Arch. Gen. Psychiat. 46 (1989) 511-517
27. Dietl M.M., Probst A., and Palacios J.M. On the distribution of cholecystokinin receptor binding sites in the human brain: An autoradiographic study. Synapse 1 (1987) 169-183
28. Dunlop J. CCK receptor antagonists. Gen. Pharmacol. 31 (1998) 519-524
29. Ebenezer I.S., and Parrott R.F. Effects of central administration of the CCK-B receptor agonist pentagastrin on feeding and cortisol release in sheep. Meth. Find. Exp. Clin. Pharmacol. 18 (1996) 235-238
30. Ebenezer I.S., Thornton S.N., and Parrott R.F. Anterior and posterior pituitary hormone release induced in sheep by cholecystokinin. Am. J. Physiol. 256 (1989) R1355-R1357
31. Ebenezer I.S., Parrott R.F., and Goode J.A. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs. Pharmacol. Biochem. Behav. 54 (1996) 255-259
32. Ehrhart-Bornstein M., Hinson J.P., Bornstein S.R., Scherbaum W.A., and Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 19 (1998) 101-143
33. Forguet-Lafitte M.E., Coudray A.M., Mester J., Gespach C., and Rosselin G. Antimitogenic effects of the gastrin-CCK receptor antagonist L-364718 and L-365260 in human colon cancer cell clone HT 29-S-B6: Cell cycle analysis and modulation by serum. Biomed. Res. 17 (1996) 457-464
34. Gallegos A.M., Schoer J.K., Starodub O., Kier A.B., Billheimer J.T., and Schroeder F. A potential role for sterol carrier protein-2 in cholesterol transfer to mitochondria. Chem. Phys. Lipids 105 (2000) 9-29
35. Ganguly A., and Davis J.S. Role of calcium and other mediators in aldosterone secretion from adrenal glomerulosa cells. Pharmacol. Rev. 46 (1994) 417-447
36. Gaumann M.D., and Yaksh T.L. Effects of hemorrhage and opiate antagonists on adrenal release of neuropeptides in cats. Peptides 9 (1988) 393-405
37. Gaumann M.D., and Yaksh T.L. Adrenal and intestinal secretion of catecholamines and neuropeptides during splanchnic artery occlusion shock. Circ. Shock 26 (1988) 391-407
38. Glasow A., and Bornstein S.R. Leptin and the adrenal gland. Eur. J. Clin. Invest. 30 (2000) 39-45
39. Hauger R.L., and Aguilera G. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: Interaction with vasopressin. Endocrinology 133 (1993) 1708-1714
40. Heym C. Immunocytochemical correlates of an extrapituitary adrenocortical regulation in man. Histol. Histopathol. 12 (1997) 567-581
41. Heym C., Braun B., Klimaschewski L., and Kummer W. Chemical codes of sensory neurons innervating the guinea-pig adrenal gland. Cell Tissue Res. 279 (1995) 169-181
42. Heym C., Braun B., Shuyi Y., Klimaschewski L., and Colombo-Benkmann M. Immunohistochemical correlation of human adrenal nerve fibres and thoracic dorsal root neurons with special reference to substance P. Histochem. Cell Biol. 104 (1995) 233-243
43. Hill D.R., Campbell N.J., Shaw T.M., and Woodruff G.N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neurosci. 7 (1987) 2967-2976
44. 3H-MK-329. J. Neurosci. 10 (1990) 1070-1081
45. Hinson J.P., Kapas S., Orford C.D., and Vinson G.P. Vasoactive intestinal peptide stimulation of aldosterone secretion by the rat adrenal cortex may be mediated by the local release of catecholamines. J. Endocrinol. 133 (1992) 253-258
46. Honda T., Wada E., Battey J.F., and Wank S.A. Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol. Cell. Neurosci. 4 (1993) 143-154
47. Houben H., and Denef C. Bioactive peptides in anterior pituitary cells. Peptides 15 (1994) 547-582
48. Itoh S., and Hirota R. Inhibitory effect of cholecystokinin octapeptide on vasoactive intestinal polypeptide-induced stimulation of adrenocortical secretion. Jpn. J. Physiol. 33 (1983) 301-304
49. Itoh S., Hirota R., Katsuura G., and Odaguchi K. Adrenocortical stimulation by a cholecystokinin preparation in the rat. Life Sci. 25 (1979) 1725-1730
50. Itoh S., Hirota R., Katsuura G., and Odaguchi K. Suppressive effect of pentagastrin on pituitary-adreno-cortical secretion. Endocrinol. Jpn. 26 (1979) 741-747
51. Itoh S., Katsuura G., Hirota R., and Odaguchi K. Effect of caerulein on plasma corticosterone concentration in the rat. Life Sci. 27 (1980) 2205-2210
52. Ivy A.C., and Oldberg E.A. A hormone mechanism for gallbladder contraction and evacuation. Am. J. Physiol. 86 (1928) 599-613
53. Jagerschmidt A., Popovici T., O' Donohue M., and Roques B.P. Identification and characterization of various cholecystokinin B receptor mRNA forms in rat brain tissue and partial determination of the cholecystokinin B receptor gene structure. J. Neurochem. 63 (1994) 1199-1206
54. Johnsen A.H. Phylogeny of the cholecystokinin/gastrin family. Front. Neuroendocrinol. 19 (1998) 73-99
55. Jorpes E., and Mutt V. Cholecystokinin and pancreozymin, one single hormone? Acta Physiol. Scand. 66 (1966) 196-202
56. Kamilaris T.C., Johnson E.O., Calogero A.E., Kalogeras K.T., Bernardini R., Chrousos G.P., and Gold P.W. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: Role of corticotropin-releasing hormone. Endocrinology 130 (1992) 1764-1774
57. Katsuura G., Ibii N., and Matsushita A. Activation of CCK-A receptors induces elevation of plasma corticosterone in rats. Peptides 13 (1992) 203-205
58. Kiss J.Z., Williams T.H., and Palkovits M. Distribution and projections of cholecystokinin-immunoreactive neurons in the hypothalamic paraventricular nucleus of rat. J. Comp. Neurol. 227 (1984) 173-181
59. Kopin A.S., McBride E.W., Schaffer K., and Beinborn M. CCK receptor polymorphisms: An illustration of emerging themes in pharmacogenomics. Trends Pharmacol. Sci. 21 (2000) 346-353
60. Krysiak R., Obuchowicz E., and Herman Z.S. Interactions between neuropeptide Y system and the hypothalamo-pituitary-adrenal axis. Eur. J. Endocrinol. 140 (1999) 130-136
61. Lehoux J.G., Mathieu A., Lavigne P., and Fleury A. Adrenocorticotropin regulation of steroidogenic acute regulatory protein. Microsc. Res. Tech. 61 (2003) 288-299
62. Liddle R.A. Cholecystokinin cells. Annu. Rev. Physiol. 59 (1997) 221-242
63. Malarkey W.B., O' Dorisio T.M., Kennedy M., and Cataland S. The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures. Life Sci. 28 (1981) 2489-2495
64. Malendowicz L.K., Jedrzejczak N., Macchi C., Markowska A., Tortorella C., Nussdorfer G.G., and Nowak M. Effects of cholecystokinin on the pituitary adrenal axis of rats with intact or regenerating adrenal glands. Biomed. Res. 19 (1998) 303-308
65. Malendowicz L.K., Trejter M., De Caro R., Jedrzejczak N., Brelinska R., Markowska A., Nussdorfer G.G., and Nowak M. Cholecystokinin, acting through the A receptor subtype, stimulates the proliferative activity of adrenocortical cells and thymocytes in the rat. Histol. Histopathol. 14 (1999) 439-443
66. Malendowicz L.K., De Caro R., Trejter M., Jedrzejczak N., Hochol A., Ziolkowska A., and Nussdorfer G.G. Endogenous cholecystokinin (CCK) exerts a tonic inhibitory action on rat pituitary-adrenocortical axis, acting through the CCK-B receptor subtype. Biomed. Res. 21 (2000) 21-23
67. Malendowicz L.K., Hochol A., Ziolkowska A., Nowak M., Gottardo L., and Nussdorfer G.G. Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland. Int. J. Mol. Med. 7 (2001) 401-404
68. Malendowicz L.K., Nowak M., Gottardo L., Tortorella C., Majchrzak M., and Nussdorfer G.G. Cholecystokinin stimulates aldosterone secretion from dispersed rat zona glomerulosa cells, acting through cholecystokinin receptors 1 and 2 coupled with the adenylate cyclase-dependent cascade. Endocrinology 142 (2001) 4251-4255
69. Malendowicz L.K., Spinazzi R., Majchrzak M., Nowak M., Nussdorfer G.G., Ziolkowska A., Macchi C., and Trejter M. Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: Role of the CCK receptor subtypes 1 and 2. Int. J. Mol. Med. 12 (2003) 903-909
70. Mazzocchi G., Malendowicz L.K., Andreis P.G., Meneghelli V., Markowska A., Belloni A.S., and Nussdorfer G.G. Neuropeptide K enhances glucocorticoid release by acting directly on the rat adrenal gland: The possible involvement of zona medullaris. Brain Res. 661 (1994) 91-96
71. Mazzocchi G., Malendowicz L.K., Macchi C., Gottardo G., and Nussdorfer G.G. Further investigations on the effects of neuropeptide Y (NPY) on the secretion and growth of rat adrenal zona glomerulosa. Neuropeptides 30 (1996) 19-27
72. Mazzocchi G., Musajo F.G., Neri G., Gottardo G., and Nussdorfer G.G. Adrenomedullin stimulates steroid secretion by the isolated perfused rat adrenal gland in situ: Comparison with calcitonin gene-related peptide effects. Peptides 17 (1996) 853-857
73. Mazzocchi G., Andreis P.G., De Caro R., Aragona F., Gottardo L., and Nussdorfer G.G. Cerebellin enhances in vitro secretory activity of human adrenal gland. J. Clin. Endocrinol. Metabol. 84 (1999) 632-635
74. Mazzocchi G., Malendowicz L.K., Gottardo L., Aragona F., and Nussdorfer G.G. Orexin-A stimulates cortisol secretion from human adrenocortical cells, through the activation of the adenylate cyclase-dependent cascade. J. Clin. Endocrinol. Metabol. 86 (2001) 778-782
75. Mazzocchi G., Malendowicz L.K., Aragona F., Spinazzi R., and Nussdorfer G.G. Cholecystokinin (CCK) stimulates aldosterone secretion from human adrenocortical cells via CCK2 receptors coupled to the adenylate cyclase/protein kinase A signaling cascade. J. Clin. Endocrinol. Metabol. 89 (2004) 1277-1284
76. Mezey E., Reisine T.D., Skirboll L., Beinfeld M., and Kiss J.Z. Role of cholecystokinin in corticotropin release: coexistence with vasopressin and corticotropin-releasing factor in cells of the rat hypothalamic paraventricular nucleus. Proc. Natl. Acad. Sci. USA 83 (1986) 3510-3512
77. Miaskiewicz S.L., Striker E.M., and Verbalis J.G. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distension in humans. J. Clin. Endocrinol. Metabol. 68 (1989) 837-843
78. Micevych P.E., Park S.S., Akesson T.R., and Elde R. Distribution of cholecystokinin-immunoreactive cell bodies in male and female rat: I. Hypothalamus. J. Comp. Neurol. 255 (1987) 124-136
79. Moran T.H., Robinson P.H., Goldrich M.S., and McHugh P.R. Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res. 362 (1986) 175-179
80. Mutt V., and Jorpes J. Structure of porcine cholecystokinin-pancreozymin. Eur. J. Biochem. 6 (1968) 156-162
81. Nagata A., Ito M., Iwata N., Kuno J., Takano H., Minowa O., Chihara K., Matsui T., and Noda T. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. USA 93 (1996) 11825-11830
82. Nair N.P.V., Lal S., Lizondo E., Eugenio H., and Guyda H. Effect of CCK-33 on prolactin and apomorphine-induced growth hormone secretion in man. Horm. Metabol. Res. 15 (1983) 357-359
83. Neri G., Andreis P.G., Prayer-Galetti T., Rossi G.P., Malendowicz L.K., and Nussdorfer G.G. Pituitary adenylate-cyclase activating peptide (PACAP) enhances aldosterone secretion of human adrenal gland: Evidence for an indirect mechanism, probably involving the local release of catecholamines. J. Clin. Endocrinol. Metabol. 81 (1996) 169-173
84. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International union of pharmacology XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51 (1999) 745-781
85. Nussdorfer G.G. Cytophysiology of the adrenal cortex. Int. Rev. Cytol. 98 (1986) 1-405
86. Nussdorfer G.G. Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol. Rev. 48 (1996) 495-530
87. Nussdorfer G.G. Proadrenomedullin-derived peptides in the paracrine control of the hypothalamo-pituitary-adrenal axis. Int. Rev. Cytol. 206 (2001) 249-284
88. Nussdorfer G.G., and Gottardo G. Neuropeptide-Y family of peptides in the autocrine-paracrine regulation of adrenocortical function. Horm. Metabol. Res. 30 (1998) 368-373
89. Nussdorfer G.G., and Malendowicz L.K. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19 (1998) 949-968
90. Nussdorfer G.G., and Malendowicz L.K. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19 (1998) 1443-1467
91. Nussdorfer G.G., Rossi G.P., Malendowicz L.K., and Mazzocchi G. Autocrine-paracrine endothelin system in the physiology and pathology of steroid-secreting tissues. Pharmacol. Rev. 51 (1999) 403-438
92. Nussdorfer G.G., Bahçelioglu M., Neri G., and Malendowicz L.K. Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus-pituitary-adrenal axis. Peptides 21 (2000) 309-324
93. Ohmori Y., Okada Y., and Watanabe T. Immunohistochemical localization of serotonin, galanin, cholecystokinin, and methionine-enkephalin in adrenal medullary cells of the chicken. Tissue Cell 29 (1997) 199-205
94. Parrott R.F., and Forsling M.L. CCK-A receptors mediate the effect of cholecystokinin on vasopressin but not on cortisol in pigs. Am. J. Physiol. 262 (1992) R1154-R1157
95. Parrott R.F., Ebenezer I.S., Baldwin B.A., and Forsling M.L. Central and peripheral doses of cholecystokinin that inhibit feeding in pigs also stimulate vasopressin and cortisol release. Exp. Physiol. 76 (1991) 525-531
96. Porter J.R., and Sander L.D. The effect of cholecystokinin octapeptide on pituitary-adrenal hormone secretion. Regul. Pept. 2 (1981) 245-252
97. Reisine T., and Jensen R. Cholecystokinin-8 stimulates adrenocorticotropin release from anterior pituitary cells. J. Pharmacol. Exp. Ther. 236 (1986) 621-626
98. Renshaw D., and Hinson J.P. Neuropeptide Y and the adrenal gland: A review. Peptides 22 (2001) 429-438
99. Renshaw D., Thomson L.M., Carroll M., Kapas S., and Hinson J.P. Actions of neuropeptide Y on the rat adrenal cortex. Endocrinology 141 (2000) 169-173
100. Ruiz-Gayo M., Garrido M.M., and Fuentes J.A. Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonist. Br. J. Pharmacol. 129 (2000) 839-842
101. Sander L.D., and Porter J.R. Influence of cholecystokinin on hypothalamic-stalk-median-eminence extract stimulation of ACTH output from isolated pituitary cells. Life Sci. 31 (1982) 1103-1110
102. Sander L.D., and Porter J.R. Influence of bombesin, CCK, secretin and CRF on corticosterone concentration in the rat. Peptides 9 (1988) 113-117
103. Sekiguchi R., and Moroji T. A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain. Brain Res. 399 (1986) 271-281
104. Spät A., and Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol. Rev. 84 (2004) 489-539
105. Späth-Schwalbe E., Piroth L., Pietrowsky R., Born J., and Fehm H.L. Stimulation of the pituitary adrenocortical system in man by caerulein, a cholecystokinin-8-like peptide. Clin. Physiol. Biochem. 6 (1988) 316-320
106. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 63 (2001) 193-213
107. Sturm K., Mac Intosh C.G., Parker B.A., Wishart J., Horowitz M., and Chapman I.M. Appetite, food intake and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women. J. Clin. Endocrinol. Metabol. 88 (2003) 3747-3755
108. Thomas R.M., and Sander L.D. Influence of CCK and bombesin on ACTH and cortisol secretion in the conscious dog. Peptides 6 (1985) 703-707
109. Todisco A., Takeuchi Y., Urumov A., Yamada J., Stepan V.M., and Yamada T. Molecular mechanisms for the growth factor action of gastrin. Am. J. Physiol. 273 (1997) G891-G898
110. Torpy D.J., Stratakis C.A., and Chrousos G.P. Hyper- and hypoaldosteronism. Vitam. Horm. 57 (2000) 177-216
111. Vanderhaeghen J.J., Signeau J.C., and Gept W. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257 (1975) 604-605
112. Vanderhaeghen J.J., Lotstra F., De May J., and Gilles C. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc. Natl. Acad. Sci. USA 77 (1980) 1190-1194
113. Vanderhaeghen J.J., Lotstra F., Vandesande F., and Dierickx K. Coexistence of cholecystokinin and oxytocin-neurophysin in some magnocellular hypothalamo-hypophyseal neurons. Cell Tissue Res. 221 (1981) 227-231
114. Vaudry D., Gonzales B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions. Pharmacol. Rev. 52 (2000) 269-324
115. Verbalis J.G., Striker E.M., Robinson A.G., and Hoffman G.E. Cholecystokinin activates c-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J. Neuroendocrinol. 3 (1991) 205-213
116. Vijayan E., and McCann S.M. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat. Life Sci. 40 (1987) 629-634
117. Vijayan E., Samson W.K., and McCann S.M. In vivo and in vitro effects of cholecystokinin on gonadotropin, prolactin, growth hormone and thyrotropin release in the rat. Brain Res. 172 (1979) 295-302
118. Wauters M., Considine R.V., and Van Gaal L.F. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur. J. Endocrinol. 143 (2000) 293-311
119. Williams J.A., Gryson K.A., and McChesney D.J. Brain CCK receptors: Species differences in regional distribution and selectivity. Peptides 7 (1986) 293-296
120. Wolf G. Orexins: A newly discovered family of hypothalamic regulators of food intake. Nutrit. Rev. 56 (1998) 172-189
121. Xu Y., Kaji H., Okimura Y., Matsui T., Abe H., and Chihara K. Paracrine stimulation of cell growth by cholecystokinin/gastrin through cholecystokinin-B receptor on GH(3) cells in vitro. Neuroendocrinology 64 (1996) 280-285
122. 3H]-SR 27897B: A selective probe for autoradiographic labelling of CCK-A receptors in the brain. J. Recept. Signal. Transduct. Res. 16 (1996) 93-113